The global isocitrate dehydrogenase (IDH) inhibitors market, valued at USD 1.7 billion in 2022, is poised for explosive growth, projected to reach an astounding USD 39.16 billion by 2033. This remarkable expansion corresponds to a CAGR of 33% during the forecast period from 2023 to 2033. The significant growth trajectory is primarily driven by the …